Showing 1,659 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Pharmaceutical industry

Gilead wins reversal of $2.54 bln hepatitis C drug patent verdict

Editor's pick
Nasdaq
19 February 2018
Elimination of hepatitis C

Hepatitis C drugs not being accessed by thousands of Australians with the disease

Editor's pick
ABC News
12 February 2018
Hepatitis B

'Virus-cracking' molecules advance fight against hepatitis B

Editor's pick
Science Daily
7 February 2018
Hepatitis C treatment

Among Those With HIV, Certain Factors Lower Chance of Curing Hep C

Editor's pick
Poz
6 February 2018
Hepatitis C treatment

Can England really eliminate hepatitis C by 2025?

Editor's pick
The Conversation UK
5 February 2018
Cancer

Deaths from liver cancer nearly double since the 1990s, new figures reveal

Editor's pick
Eurekalert Medicine & Health
1 February 2018
Hepatitis C treatment

Georgia: 98% of people in Hepatitis C elimination program cured

Editor's pick
Agenda.ge
31 January 2018
Hepatitis C treatment

NHS England sets out plans to be first in the world to eliminate Hepatitis C

Editor's pick
NHS England
29 January 2018
Hepatitis C treatment

Managing the Fruits of HCV Cure: How Much Care do the Cured Need?

Editor's pick
Healio
22 January 2018
Hepatitis C treatment

India to launch national program to control viral hepatitis and aims to negotiate lower drug prices

Editor's pick
Pharma Letter
9 January 2018
Hepatitis C treatment

England: 25,000 Hepatitis C patients receive new treatments

Editor's pick
NHS England
8 January 2018
Hepatitis C treatment

HCV Genotype 6 Responds to 8-Week Oral Treatment

Editor's pick
MD
2 January 2018
Hepatitis C treatment

Should uninfected patients accept hepatitis C-infected livers to reduce waiting time?

Editor's pick
Eurekalert Inf Dis
20 December 2017
Harm reduction

Harm reduction approaches predicted to reduce rates of new hepatitis C infection for people who inject drugs

Editor's pick
National Institute for Health Research
8 December 2017
Hepatitis C treatment

MSF: People co-infected with HIV to receive hepatitis C treatment in Mykolaiv region

Editor's pick
UNIAN
4 December 2017
Hepatitis C treatment

Gilead prices hepatitis C giant Sovaldi in China at one-fifth the US price: report

Editor's pick
FiercePharma
29 November 2017
Harm reduction

How Drug Users Would Solve the Opioid Crisis

Editor's pick
Vice
15 November 2017
Hepatitis A

Merck, GlaxoSmithKline face hepatitis A vaccine shortage amid US outbreaks

Editor's pick
FiercePharma
15 November 2017
Hepatitis & HIV

Eliminating viral hepatitis: time to match visions with action

Editor's pick
The Lancet (editorial)
10 November 2017
Hepatitis & HIV

8 things to know ahead of the World Hepatitis Summit

Editor's pick
Devex
2 November 2017
Hepatitis C treatment

Nine countries now on track to eliminate hepatitis

Editor's pick
World Hepatitis Summit
1 November 2017
Access to healthcare

MSF Secures Deals For Key Hepatitis C Medicines, Price A Fraction Of Branded Drug

Editor's pick
Intellectual Property Watch
31 October 2017
Hepatitis C treatment

Close to 3 million people access hepatitis C cure

Editor's pick
World Health Organization
31 October 2017
Pharmaceutical industry

Gilead HCV drug sales down in 2017 third quarter compared with 2016

Editor's pick
Healio
31 October 2017